Literature DB >> 1638716

Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms.

R C Saumarez1, A J Camm, A Panagos, J S Gill, J T Stewart, M A de Belder, I A Simpson, W J McKenna.   

Abstract

BACKGROUND: Intraventricular conduction in hypertrophic cardiomyopathy (HCM) has been characterized to test the hypothesis that myofibrillar disarray will cause dispersion of activation throughout the ventricular myocardium. METHODS AND
RESULTS: Of 37 patients with HCM, four had spontaneous ventricular fibrillation (VF), five had nonsustained ventricular tachycardia (VT), 13 had no risk factors, and 15 had a family history of sudden death. These patients and four controls were studied by pacing one site in the right ventricle and recording electrograms from three other right ventricular sites. These electrograms were high-pass filtered to emphasize small deflections due to activation of small bundles of myocytes close to the electrode. Intraventricular conduction curves were obtained with S1S2 coupling intervals decreasing in 1-msec steps from 479 msec to ventricular effective refractory period (VERP). These curves were repeated by pacing each RV site in turn and were characterized by two parameters: the point at which latency increased by 0.75 msec/20 msec reduction of the S1S2 coupling interval and an increase in electrogram duration between an S1S2 of 350 msec and VERP. Patients with VF, VT, and family history of sudden death had a mean increase in electrogram duration of 12.8 (2.9-32.3) msec versus 4.6 (-4.2 to 14.0) msec in low-risk patients and controls. Electrogram latency increased at an S1S2 of 363 msec in the VF group (342-386), 269 msec in the controls (266-279), and 326 msec in the non-VF group (260-399). Discriminant analysis separated VF patients from the remainder (p less than 0.0001) and VF, VT, and family history of sudden death patients from the low-risk and control groups (p less than 10(-6)).
CONCLUSIONS: Patients with HCM who are at risk of sudden death have increased dispersion and inhomogeneity of intraventricular conduction, and this may create the conditions for reentry and arrhythmogenesis.

Entities:  

Mesh:

Year:  1992        PMID: 1638716     DOI: 10.1161/01.cir.86.2.467

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

1.  Ventricular arrhythmogenesis following slowed conduction in heptanol-treated, Langendorff-perfused mouse hearts.

Authors:  Gary Tse; Sandeep S Hothi; Andrew A Grace; Christopher L-H Huang
Journal:  J Physiol Sci       Date:  2012-01-05       Impact factor: 2.781

Review 2.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  Divergence of endocardial QT interval components during programmed electrical stimulation including observations during induction of sustained ventricular tachyarrhythmias.

Authors:  D G Wyse; L B Mitchell; R S Sheldon; A M Gillis; H J Duff
Journal:  J Interv Card Electrophysiol       Date:  1997-02       Impact factor: 1.900

Review 4.  Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Julian O M Ormerod; Michael P Frenneaux; Mark V Sherrid
Journal:  Nat Rev Cardiol       Date:  2016-07-14       Impact factor: 32.419

5.  Hypertrophic cardiomyopathy with apical aneurysm: a case of catheter and surgical therapy of sustained monomorphic ventricular tachycardia.

Authors:  M Mantica; P Della Bella; V Arena
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

6.  Screening for hypertrophic cardiomyopathy.

Authors:  G R McLatchie; D S Pedoe; W J McKenna; C Butler; W S Hillis; G Davies; T Yorath; M J Davies; J F Goodwin
Journal:  BMJ       Date:  1993-03-27

7.  Genetic investigation and counselling of families with hypertrophic cardiomyopathy.

Authors:  M J Davies; D M Krikler
Journal:  Br Heart J       Date:  1994-08

8.  Electrophysiological investigation of patients with hypertrophic cardiomyopathy. Evidence that slowed intraventricular conduction is associated with an increased risk of sudden death.

Authors:  R C Saumarez
Journal:  Br Heart J       Date:  1994-12

9.  Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy.

Authors:  Stephan Fluechter; Jürgen Kuschyk; Christian Wolpert; Christina Doesch; Christian Veltmann; Dariusch Haghi; Stefan O Schoenberg; Tim Sueselbeck; Tjeerd Germans; Florian Streitner; Martin Borggrefe; Theano Papavassiliu
Journal:  J Cardiovasc Magn Reson       Date:  2010-05-21       Impact factor: 5.364

Review 10.  Management of arrhythmias in hypertrophic cardiomyopathy.

Authors:  J T Stewart; W J McKenna
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.